\-\ Texto\\:\\ \ \(0\)\
\-\ admission\\ labs\\:\ \(0\)\
\-\ s\\/p\\ ercp\\ cytopathology\\:\ \(0\)\
\-\ 1\\)\\ pancreatic\\ duct\\ brushing\\ \\-\\ adenocarcinoma\\.\ \(0\)\
\-\ 2\\)\\ common\\ bile\\ duct\\ brushing\\ \\-\\ atypical\\ cells\\ nos\\.\ \(0\)\
\-\ surgery\\ is\\ only\\ option\\ with\\ cytopathologic\\ diagnosis\\ of\\ pancreatic\\ ductal\\ adenocarcinoma\\.\\ unlikely\\ surgical\\ candidate\\ given\\ signs\\ of\\ unresectable\\ disease\\ with\\ evidence\\ of\\ regional\\ nodal\\ spread\\.\\ palliative\\ stenting\\ of\\ obstructed\\ common\\ bile\\ duct\\ has\\ been\\ appropriately\\ instituted\\.\ \(0\)\
\-\ ercp\\:\\ \ \(0\)\
\-\ 1\\)\\ double\\ duct\\ sign\\ \\-\\ cbd\\ and\\ pancreatic\\ ductal\\ obstruction\\ with\\ consequent\\ proximal\\ ductal\\ dilitation\\.\ \(0\)\
\-\ ct\\,\\ contrast\\-enhanced\\:\ \(0\)\
\-\ 1\\)\\ pancreatic\\ ductal\\ dilitation\\ with\\ hypodense\\ region\\ within\\ pancreatic\\ head\\ which\\ may\\ represent\\ volume\\ averaging\\ and\\/or\\ site\\ pancreatic\\ ductal\\ cancer\\.\ \(0\)\
\-\ 2\\)\\ 1\\.2\\ cm\\ peripancreatic\\ node\\.\ \(0\)\
\-\ 3\\)\\ common\\ bile\\ duct\\ s\\/p\\ stent\\ placement\\.\ \(0\)\
\-\ mrcp\\:\ \(0\)\
\-\ 1\\)\\ consistent\\ with\\ ercp\\ findings\\ as\\ above\\.\ \(0\)\
\-\ pancreatic\\ ductal\\ adenocarcinoma\ \(0\)\
\-\ 1\\)\\ other\\ exocrine\\ tumors\\ of\\ pancreatic\\ head\\:\\ cystic\\ neoplasm\\ \\(micro\\-\\,\\ macrocystic\\ adenoma\\)\\,\\ intraductal\\ papillary\\ mucinous\\ tumor\\.\ \(0\)\
\-\ 2\\)\\ endocrine\\ tumors\\ of\\ pancreas\\:\\ insulinoma\\,\\ gastrinoma\\,\\ nonfunctioning\\ islet\\ cell\\ tumor\ \(0\)\
\-\ 3\\)\\ lymphoma\ \(0\)\
\-\ 4\\)\\ metastatic\\ disease\ \(0\)\
\-\ 5\\)\\ pancreatitis\ \(0\)\
\-\ 47\\ year\\ old\\ male\\ presents\\ with\\ painless\\ obstructive\\ jaundice\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pancreatic\\:\\ 0\\.16892078528229748\ \(0\)\
\-\ ductal\\:\\ 0\\.12206141458134705\ \(0\)\
\-\ duct\\:\\ 0\\.09893127838423199\ \(0\)\
\-\ brushing\\:\\ 0\\.08904564064612626\ \(0\)\
\-\ ercp\\:\\ 0\\.08673448440315427\ \(0\)\
\-\ bile\\:\\ 0\\.06919732093813848\ \(0\)\
\-\ dilitation\\:\\ 0\\.05829288874993006\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.05593264309944302\ \(0\)\
\-\ 1\\:\\ 0\\.05134662545352795\ \(0\)\
\-\ \\)\\:\\ 0\\.046848434330671554\ \(0\)\
\-\ micro\\-\\:\\ 0\\.04452282032306313\ \(0\)\
\-\ \\:\\:\\ 0\\.03995921066633664\ \(0\)\
\-\ cytopathology\\:\\ 0\\.03897427341059793\ \(0\)\
\-\ cytopathologic\\:\\ 0\\.03897427341059793\ \(0\)\
\-\ consequent\\:\\ 0\\.03897427341059793\ \(0\)\
\-\ nos\\:\\ 0\\.037521333650740445\ \(0\)\
\-\ averaging\\:\\ 0\\.037521333650740445\ \(0\)\
\-\ exocrine\\:\\ 0\\.037521333650740445\ \(0\)\
\-\ insulinoma\\:\\ 0\\.0363943460178404\ \(0\)\
\-\ s\\/p\\:\\ 0\\.03620615966779709\ \(0\)\
\-\ unresectable\\:\\ 0\\.035473530074436585\ \(0\)\
\-\ gastrinoma\\:\\ 0\\.035473530074436585\ \(0\)\
\-\ nonfunctioning\\:\\ 0\\.035473530074436585\ \(0\)\
\-\ cbd\\:\\ 0\\.0340205903145791\ \(0\)\
\-\ common\\:\\ 0\\.0338828365447939\ \(0\)\
\-\ macrocystic\\:\\ 0\\.03342572649813272\ \(0\)\
\-\ peripancreatic\\:\\ 0\\.032893602681679054\ \(0\)\
\-\ tumors\\:\\ 0\\.03242137735020709\ \(0\)\
\-\ instituted\\:\\ 0\\.03241223813721277\ \(0\)\
\-\ mrcp\\:\\ 0\\.03156853063891395\ \(0\)\
\-\ islet\\:\\ 0\\.031194247951268888\ \(0\)\
\-\ nodal\\:\\ 0\\.02891149480105143\ \(0\)\
\-\ intraductal\\:\\ 0\\.02868699094968358\ \(0\)\
\-\ stenting\\:\\ 0\\.028067787302752608\ \(0\)\
\-\ obstructed\\:\\ 0\\.028067787302752608\ \(0\)\
\-\ 2\\:\\ 0\\.0278803711592507\ \(0\)\
\-\ \\-\\:\\ 0\\.027753461495581267\ \(0\)\
\-\ regional\\:\\ 0\\.027345055769213852\ \(0\)\
\-\ 1\\.2\\:\\ 0\\.027179450603441173\ \(0\)\
\-\ appropriately\\:\\ 0\\.026863691224747566\ \(0\)\
\-\ endocrine\\:\\ 0\\.02671291868358756\ \(0\)\
\-\ candidate\\:\\ 0\\.026566516982207498\ \(0\)\
\-\ palliative\\:\\ 0\\.026285861168294313\ \(0\)\
\-\ mucinous\\:\\ 0\\.025892116009356373\ \(0\)\
\-\ jaundice\\:\\ 0\\.02576740584475854\ \(0\)\
\-\ head\\:\\ 0\\.024480821318928245\ \(0\)\
\-\ stent\\:\\ 0\\.02428376383199004\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.024192761278946207\ \(0\)\
\-\ option\\:\\ 0\\.02410336947541388\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.023678707267279834\ \(0\)\
\-\ hypodense\\:\\ 0\\.022994134075379712\ \(0\)\
\-\ 47\\:\\ 0\\.022650429715556402\ \(0\)\
\-\ obstructive\\:\\ 0\\.022205443516009598\ \(0\)\
\-\ pancreas\\:\\ 0\\.022085187714526174\ \(0\)\
\-\ papillary\\:\\ 0\\.021910008128728748\ \(0\)\
\-\ painless\\:\\ 0\\.0216855042773609\ \(0\)\
\-\ spread\\:\\ 0\\.020875692913344842\ \(0\)\
\-\ double\\:\\ 0\\.020875692913344842\ \(0\)\
\-\ unlikely\\:\\ 0\\.02055851664446085\ \(0\)\
\-\ volume\\:\\ 0\\.020385832984116004\ \(0\)\
\-\ 3\\:\\ 0\\.020211874007136765\ \(0\)\
\-\ tumor\\:\\ 0\\.02012355860212941\ \(0\)\
\-\ node\\:\\ 0\\.019748705280444794\ \(0\)\
\-\ admission\\:\\ 0\\.019018497054126067\ \(0\)\
\-\ represent\\:\\ 0\\.018954158540098645\ \(0\)\
\-\ atypical\\:\\ 0\\.01870470017984826\ \(0\)\
\-\ and\\/or\\:\\ 0\\.018239958267119712\ \(0\)\
\-\ site\\:\\ 0\\.018239958267119712\ \(0\)\
\-\ adenoma\\:\\ 0\\.018022698746495012\ \(0\)\
\-\ placement\\:\\ 0\\.017517226733580957\ \(0\)\
\-\ cells\\:\\ 0\\.017305286334090897\ \(0\)\
\-\ above\\:\\ 0\\.01581787200317079\ \(0\)\
\-\ obstruction\\:\\ 0\\.01521919216459311\ \(0\)\
\-\ signs\\:\\ 0\\.015188767343363913\ \(0\)\
\-\ labs\\:\\ 0\\.015009969731995648\ \(0\)\
\-\ sign\\:\\ 0\\.01495175000890945\ \(0\)\
\-\ given\\:\\ 0\\.014795022184425974\ \(0\)\
\-\ neoplasm\\:\\ 0\\.01469776048440368\ \(0\)\
\-\ cancer\\:\\ 0\\.014187703355377604\ \(0\)\
\-\ disease\\:\\ 0\\.014108460012279842\ \(0\)\
\-\ only\\:\\ 0\\.012976826558004726\ \(0\)\
\-\ proximal\\:\\ 0\\.012957288796500077\ \(0\)\
\-\ 5\\:\\ 0\\.012627072840627088\ \(0\)\
\-\ cystic\\:\\ 0\\.012447639935614943\ \(0\)\
\-\ lymphoma\\:\\ 0\\.012334336537320635\ \(0\)\
\-\ region\\:\\ 0\\.012189905188077338\ \(0\)\
\-\ 4\\:\\ 0\\.0120251106322174\ \(0\)\
\-\ been\\:\\ 0\\.01174138833062622\ \(0\)\
\-\ cell\\:\\ 0\\.011657781371623668\ \(0\)\
\-\ cm\\:\\ 0\\.011575535948570637\ \(0\)\
\-\ evidence\\:\\ 0\\.011315366582661\ \(0\)\
\-\ metastatic\\:\\ 0\\.010864188907151972\ \(0\)\
\-\ consistent\\:\\ 0\\.010582314489046481\ \(0\)\
\-\ surgery\\:\\ 0\\.010479793254344824\ \(0\)\
\-\ other\\:\\ 0\\.009947669437891155\ \(0\)\
\-\ diagnosis\\:\\ 0\\.009910198640305151\ \(0\)\
\-\ may\\:\\ 0\\.009466304893424869\ \(0\)\
\-\ findings\\:\\ 0\\.009186045130252321\ \(0\)\
\-\ surgical\\:\\ 0\\.00907182712248209\ \(0\)\
\-\ presents\\:\\ 0\\.00881638533084811\ \(0\)\
\-\ within\\:\\ 0\\.008232986911040817\ \(0\)\
\-\ has\\:\\ 0\\.008104545305526657\ \(0\)\
\-\ which\\:\\ 0\\.008056285794154287\ \(0\)\
\-\ male\\:\\ 0\\.007804068373169057\ \(0\)\
\-\ \\,\\:\\ 0\\.006836112765588065\ \(0\)\
\-\ as\\:\\ 0\\.006528169221687515\ \(0\)\
\-\ ct\\:\\ 0\\.006036887138343652\ \(0\)\
\-\ year\\:\\ 0\\.004828814491277348\ \(0\)\
\-\ old\\:\\ 0\\.004418861600314418\ \(0\)\
\-\ \\(\\:\\ 0\\.0036482915466861648\ \(0\)\
\-\ with\\:\\ 0\\.0035455810936330222\ \(0\)\
\-\ of\\:\\ 0\\.0035304182059996496\ \(0\)\
\-\ is\\:\\ 0\\.002839852416084473\ \(0\)\
\-\ \\.\\:\\ 0\\.0021514870362028047\ \(0\)\
\-\ and\\:\\ 0\\.0009091363925869619\ \(0\)\
